Type 2 Diabetes: How Much of an Autoimmune Disease?
Type 2 diabetes (T2D) is characterized by a progressive status of chronic, low-grade inflammation (LGI) that accompanies the whole trajectory of the disease, from its inception to complication development. Accumulating evidence is disclosing a long list of possible “triggers” of inflammatory respons...
Main Authors: | Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Veronica De Rosa, Mario Galgani, Francesca Di Rella, Maria Immacolata Spagnuolo, Alessandra Colamatteo, Clorinda Fusco, Teresa Micillo, Sara Bruzzaniti, Antonio Ceriello, Annibale A. Puca, Giuseppe Matarese |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00451/full |
Similar Items
-
Metabolism and Autoimmune Responses: The microRNA Connection
by: Alessandra Colamatteo, et al.
Published: (2019-08-01) -
Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity
by: Silvia Garavelli, et al.
Published: (2020-01-01) -
Effect of time and titer in convalescent plasma therapy for COVID-19
by: Paola de Candia, et al.
Published: (2021-08-01) -
Variability of risk factors and diabetes complications
by: Antonio Ceriello, et al.
Published: (2021-05-01) -
Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation
by: Alessandra Colamatteo, et al.
Published: (2020-02-01)